Understanding how epigenetics influences blood stem cell development
Determinants of epigenetic inheritance in human stem cell fate decisions
This study looks at how certain proteins influence the way blood stem cells decide to either make more stem cells or turn into different types of blood cells, which could help improve treatments for blood cancers like acute myeloid leukemia.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10891483 on NIH RePORTER |
What this research studies
This research investigates the role of epigenetics in the fate decisions of hematopoietic stem cells (HSCs), which are crucial for blood formation. The study focuses on how certain proteins, particularly nucleophosmin (NPM1), affect the inheritance of chromatin states during cell division. By examining these mechanisms, the research aims to uncover how HSCs can both self-renew and differentiate into various blood cell types. Patients may benefit from insights that could lead to improved treatments for blood cancers like acute myeloid leukemia (AML).
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with acute myeloid leukemia or related blood disorders.
Not a fit: Patients with non-hematological conditions or those not diagnosed with blood cancers may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating blood cancers by targeting the epigenetic mechanisms involved in stem cell behavior.
How similar studies have performed: Previous research has shown promising results in understanding epigenetic mechanisms in stem cells, suggesting that this approach could yield valuable insights.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Escobar, Thelma — University of Washington
- Study coordinator: Escobar, Thelma
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.